Trial intelligence / Profile preview

Stannous fluoride toothpaste for gingivitis in healthy and unhealthy subjects

NCT05326373Completed

Sponsor
Procter & Gamble
Start
Apr 2022
Primary completion
Jun 2022
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Open-label trial of stannous fluoride in gingivitis (2 arms), sponsored by Procter & Gamble. Primary endpoints: Modified Gingival Index at 8 weeks and Gingival Bleeding Index at 8 weeks. Started Apr 2022; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT05326373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05326373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call